Emergent BioSolutions (EBS) Misses Q3 EPS by $2.71
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.47 +0.45%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of ($0.36), $2.71 worse than the analyst estimate of $2.35. Revenue for the quarter came in at $329 million versus the consensus estimate of $486.84 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emergent BioSolutions (EBS) PT Lowered to $10 at H.C. Wainwright
- Sutro Biopharma Inc. (STRO) Misses Q2 EPS by 13c
- SunEdison (SUNE) Misses Q2 EPS by 52c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
